ABOUT US
Maver Capital was co-founded in 2022 by a group of seasoned banking professionals, investors, business operators and entrepreneurs in Hong Kong. We target investments in three fast-growing sectors — healthcare, consumer and technology.
Based in Hong Kong we have a pan-Asia Pacific focus with an international outlook. Proprietary access to the Hong Kong Science & Technology Park (HKSTP), Hong Kong’s biggest innovation ecosystem, further defines its uniqueness. Our private equity investment mandate spans across the full life cycle of businesses, including early-stage funding as well as late-stage growth capital.
We support entrepreneurs who possess the vision, determination, and willingness to work together in transforming big ideas into even bigger businesses. We pride in helping our founders build global businesses with our experienced network of operators & advisors. .
TECH
Investing
Focuses on identifying innovative companies with disruptive technologies that have the potential to revolutionize industries. We carefully analyze market trends, evaluate the strength of the management team, and assess the scalability of the business model. Our approach combines a blend of research, due diligence, and strategic partnerships to maximize long-term growth and success.
CONSUMER
Investing
Focuses on identifying innovative startups that address emerging consumer trends and preferences. This could include companies developing disruptive technologies in e-commerce, personalized consumer experiences, health and wellness, sustainable products, and digital entertainment.
HEALTHCARE
Investing
Centers around identifying companies that are at the forefront of medical innovation and have the potential to improve patient outcomes and transform the healthcare industry. We focus on areas such as biotechnology, digital health, medical devices, and AI-driven diagnostics and carefully evaluate the clinical efficacy, market potential, and regulatory landscape of potential investments.